The production and use of cells as therapeutic agents in neurodegenerative diseases.
about
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's diseaseLong-term, stable differentiation of human embryonic stem cell-derived neural precursors grafted into the adult mammalian neostriatumLocal transplantation of granulocyte colony-stimulating factor-mobilized human peripheral blood mononuclear cells for unhealing bone fractures.Immature and neurally differentiated mouse embryonic stem cells do not express a functional Fas/Fas ligand system.Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord.Stem cell therapy for Parkinson's disease.Sorting the wheat from the chaff in dopamine neuron-based cell therapies.Dynamic expression of the pro-dopaminergic transcription factors Pax6 and Dlx2 during postnatal olfactory bulb neurogenesis.The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease.Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populationsBioreactors for extracorporeal liver support.Restoration of calbindin after fetal hippocampal CA3 cell grafting into the injured hippocampus in a rat model of temporal lobe epilepsy.A tyrosine hydroxylase-yellow fluorescent protein knock-in reporter system labeling dopaminergic neurons reveals potential regulatory role for the first intron of the rodent tyrosine hydroxylase gene.Neural stem cell transplantation for the treatment of primary torsion dystonia: A case reportFate mapping and lineage analyses demonstrate the production of a large number of striatal neuroblasts after transforming growth factor alpha and noggin striatal infusions into the dopamine-depleted striatumStem cells and neurodegenerative diseases.Bioartificial liver systems: why, what, whither?Future of cell and gene therapies for Parkinson's disease.Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson's disease.Neuronal Circuitry Mechanisms Regulating Adult Mammalian Neurogenesis.Primate adult brain cell autotransplantation, a pilot study in asymptomatic MPTP-treated monkeys.Dopaminergic differentiation of human neural stem cells mediated by co-cultured rat striatal brain slices.Ole Isacson: development of new therapies for Parkinson's disease (interview).The Gordon Wilson lecture: using genetic medicine to regenerate diseased organs and protect against the hostile environment.Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro.Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors.Primate adult brain cell autotransplantation produces behavioral and biological recovery in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian St. Kitts monkeys.Allorecognition of human neural stem cells by peripheral blood lymphocytes despite low expression of MHC molecules: role of TGF-beta in modulating proliferation.Intrastriatal Transplantation of Human Neural Stem Cells Restores the Impaired Subventricular Zone in Parkinsonian Mice.An in-vivo paradigm for the evaluation of stimulating electrodes for use with a visual prosthesis.Stem cell transplantation in amyotrophic lateral sclerosis patients: methodological approach, safety, and feasibility
P2860
Q29619506-4E6591E4-8E3E-4572-9ACC-7B317F1704AEQ34003304-18C164C8-8350-408B-97A0-6A15230E72E9Q34022441-E3575CE8-4878-4867-98F9-D902FD22976EQ34182377-879E2B82-21D5-442A-AA83-F56D79318624Q34309273-94588A90-6AC9-4C63-A010-54130A805FD7Q35236822-2C3E4A6E-6554-47C5-B453-D1F567E9D15BQ35485792-5ED20328-34B3-4EA4-82AA-9372EF6FEB1CQ35771486-55AEDBB0-5AB0-41F5-898B-A06600239255Q36045254-6CFAD796-5988-48EE-85DE-B99AE7A2FB5AQ36326475-B18EDFE5-A01D-46CB-8C9A-203B5A6E25A7Q36453736-6CE2E19E-7FA3-4F77-B568-5FE241B28F84Q36530003-91170181-DE22-4591-A0A7-B9C9AE87D386Q36729198-ED531952-67ED-460C-AB06-21316D198138Q37029654-480C7CF8-D9D3-4083-97D4-3CA9F11FBFD8Q37108283-DFD9AF05-02B1-49A7-8DF3-A6C798502062Q37113840-E53325B7-6D0B-4F0F-93BE-4187373189D1Q37119760-0F7D616F-51D4-47F6-85A5-57FB3978AC50Q37202810-60C55F18-CACA-486B-BAD9-D4413CEA0EDDQ37696495-5617A27E-6493-4BA0-BB42-C71EC9E74768Q37872232-EE3AAB03-F017-4341-81E9-4653A9BABC14Q38825006-3C7E8309-ADF9-4177-A909-05CB6138E454Q39973294-1B2ED61C-2705-4389-B225-50D8472A5A75Q40025358-6A311045-9653-41A2-84D0-F1310A874668Q42047623-3E5F0011-644F-45CA-9DE5-6FA722E6672BQ43070160-E5333583-9578-46D5-A88D-A74C38E176DEQ43213925-E17A5213-778F-417E-B192-E01F5D0637E8Q45049892-5944940A-54D8-4808-AAD5-2C78205B1319Q46921956-1D84082B-6F66-4753-9D30-949C3E53E47AQ48092257-33D29B5C-54D5-4455-967A-ED89640E0D4DQ48092963-B5E08922-AB11-43F8-9E51-7AEF7D24DFA7Q51674683-79F34749-0082-4BFD-B09A-736BA382530BQ56775496-0B822EBB-0BA6-4C37-BB46-D452AEC39736
P2860
The production and use of cells as therapeutic agents in neurodegenerative diseases.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The production and use of cells as therapeutic agents in neurodegenerative diseases.
@ast
The production and use of cells as therapeutic agents in neurodegenerative diseases.
@en
type
label
The production and use of cells as therapeutic agents in neurodegenerative diseases.
@ast
The production and use of cells as therapeutic agents in neurodegenerative diseases.
@en
prefLabel
The production and use of cells as therapeutic agents in neurodegenerative diseases.
@ast
The production and use of cells as therapeutic agents in neurodegenerative diseases.
@en
P1433
P1476
The production and use of cells as therapeutic agents in neurodegenerative diseases.
@en
P2093
Ole Isacson
P304
P356
10.1016/S1474-4422(03)00437-X
P577
2003-07-01T00:00:00Z